UNSPSC 51142425: Dihydroergotamine methanesulfonate

This classification denotes a nonnarcotic analgesic and dopamine agonist with the molecular formula C33H37N5O5.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 81AXN7R2QT, chemically known as ergotoman-3',6',18-trione,9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'.alpha.)-, monomethanesulfonate (salt), but more generally known as dihydroergotamine methanesulfonate, which bears US NIH Compound Identifier 10531.

European Medicines Agency schedules dihydroergotamine methanesulfonate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07139MIG. Most nations, for tariff purposes, schedule dihydroergotamine methanesulfonate under HS 29396900. SMILES: C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4CCCCC4)NC(=O)[C@@H]5C[C@@H]6C7CCCC8C7C(C[NH]8)C[C@H]6N(C5)C.CS(=O)(=O)O.

UNSPSC 51142425 Dihydroergotamine methanesulfonate, a Commodity code, nominally covers a specific migraine and ergot-based pharmaceutical product, but the recent state and local opportunities tagged to this code show little relevant activity. The three posted solicitations address naloxone and drug deactivation systems (Seminole County, Florida), a direct-to-manufacturer pharmacy prescription program (Texas HHS Commission), and generic multi-source pharmaceuticals and OTC products through a cooperative purchasing vehicle (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). None of these opportunities directly procure dihydroergotamine methanesulfonate or align with the commodity's stated scope. The code appears underutilized or mistagged in the state and local procurement system, with no current solicitations targeting this pharmaceutical specifically.

State and local procurement activity under this Commodity code does not present a clear or active market. The three recent opportunities represent broader pharmaceutical procurement categories—emergency response drugs, pharmacy benefit management reform, and cooperative generic-drug supply contracting—rather than targeted demand for this particular ergot-derived agent. Issuing bodies include a county health department (Seminole County), a state health and human services commission (Texas HHS), and a multistate cooperative purchasing alliance (MMCAP, administered by Minnesota). Geographic reach spans Florida, Texas, and Minnesota with participation from Oregon. Unless forthcoming solicitations specifically name dihydroergotamine methanesulfonate as a line item or bundled pharmaceutical within a larger contract, the code signals low procurement urgency and warrants close monitoring rather than active pursuit at this time.